UNSPSC 51302305: Chlordantoin or clodantoin

This classification denotes an antifungal agent with the molecular formula C11H17Cl3N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W14Z7581PA, chemically known as 1-pentanol, acetate but generally known as chlordantoin, which bears US NIH Compound Identifier 12348. European Medicines Agency schedules Clodantoin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06690MIG.

The term CLODANTOIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules chlordantoin in its Anatomical Therapeutic Chemical (ATC) Classification. Chlordantoin or clodantoin bears US NLM identifiers UMLS ID C0055903 and NCI Concept Code C75200. SMILES: CCCCC(CC)C1C(=O)N(C(=O)N1)SC(CL)(CL)CL.

UNSPSC 51302305 Chlordantoin or clodantoin is a Commodity code covering disinfectant and antimicrobial chemical compounds used in medical and first-aid applications. In practice, state and local governments procure this code as part of broader medical supply and first-aid kit sourcing, typically bundled with antiseptic sprays, hydrogen peroxide, bandages, pain relievers, and emergency medical consumables. The City of Tampa Fire Rescue Department's recent ITB procurement illustrates typical demand: the department sought a comprehensive suite of 32 medical and first-aid supply items including disinfectants and related products, with annual volumes ranging from single units to 2,700 units per item depending on the specific product line. Fire and rescue departments are the primary issuing bodies under this code, procuring supplies for station inventory, emergency response kits, and field-deployed first-aid operations. The code sees activity from municipal fire departments and emergency services divisions within city and county governments.

The most recent solicited opportunity is ITB 25-P-00157 from the City of Tampa Fire Rescue Department, posted April 24, 2026, with an original response deadline of April 9, 2025 (note: the posted date postdates the original due date, indicating addenda or timeline adjustments). The total departmental budget for the procurement was $100,000, with a one-year initial award period and two optional one-year renewals. The solicitation included set-aside provisions offering a 5% bid discount for City-certified Small Local Business Enterprises (SLBE), not to exceed $10,000, and Underutilized Woman and Minority Owned Business Enterprises (U-WMBE), not to exceed $20,000, targeting underutilized businesses owned by African American, Hispanic, Asian, Native American, and women business owners. Bidders were required to meet a nine-month minimum expiration date on all medications from acceptance. Geographic activity under this code is limited; the recent-opportunities block shows a single municipal procurement from Florida.